摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(-)-(3R,4S)-2-benzyloxycarbonyl-1-(tert-butoxycarbonyl)-3-tert-butyldimethylsilyloxymethyl-4-phenylpyrazolidine | 224572-15-0

中文名称
——
中文别名
——
英文名称
(-)-(3R,4S)-2-benzyloxycarbonyl-1-(tert-butoxycarbonyl)-3-tert-butyldimethylsilyloxymethyl-4-phenylpyrazolidine
英文别名
——
(-)-(3R,4S)-2-benzyloxycarbonyl-1-(tert-butoxycarbonyl)-3-tert-butyldimethylsilyloxymethyl-4-phenylpyrazolidine化学式
CAS
224572-15-0
化学式
C29H42N2O5Si
mdl
——
分子量
526.748
InChiKey
KZHPLQWWMOZXSX-RPBOFIJWSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

反应信息

  • 作为反应物:
    描述:
    (-)-(3R,4S)-2-benzyloxycarbonyl-1-(tert-butoxycarbonyl)-3-tert-butyldimethylsilyloxymethyl-4-phenylpyrazolidine 在 jones reagent 作用下, 以97%的产率得到(-)-<(3R,4S)-2-benzyloxycarbonyl-1-(tert-butoxycarbonyl)-4-phenylpyrazolidine>carboxylic acid
    参考文献:
    名称:
    First Highly Regio- and Diastereoselective [3+2] Cycloaddition of Chiral Nonracemic Alkenyl Fischer Carbene Complexes with Diazomethane Derivatives: Preparation and Synthetic Applications of Enantiomerically Pure Δ2-Pyrazolines
    摘要:
    The [3+2] cycloaddition of alkenyl Fischer carbene complexes 1 and 6 with diazomethane derivatives to give Delta(2)-pyrazoline carbenes 2, 4, and 7 is described. The conversion of (-)-8-phenylmenthol-derived carbenes 6 into pyrazoline esters 9 through a one-pot cycloaddition-protection-oxidation is presented as an expeditious route to enantiomerically pure 3-alkoxycarbon-yl-Delta(2)-pyrazolines in good yields and in a highly regio- and diastereoselective manner. Pyrazolidines 13 were synthesized in excellent overall yields from 9 through pyrazolines 11 and 12, the diastereoselective reduction of C=N bond being the key step. Azaprolines 16 and 17 were prepared in very good yields from epimeric trans-13 or cis-13 by oxidative deprotection of the silylated hydroxy group. In an alternative reaction, the pyrazolidine ring of 13 was reduced to obtain protected open-chain 2,4-diamino alcohols 19 with three chiral centers.
    DOI:
    10.1002/(sici)1521-3765(19990301)5:3<883::aid-chem883>3.0.co;2-0
  • 作为产物:
    参考文献:
    名称:
    First Highly Regio- and Diastereoselective [3+2] Cycloaddition of Chiral Nonracemic Alkenyl Fischer Carbene Complexes with Diazomethane Derivatives: Preparation and Synthetic Applications of Enantiomerically Pure Δ2-Pyrazolines
    摘要:
    The [3+2] cycloaddition of alkenyl Fischer carbene complexes 1 and 6 with diazomethane derivatives to give Delta(2)-pyrazoline carbenes 2, 4, and 7 is described. The conversion of (-)-8-phenylmenthol-derived carbenes 6 into pyrazoline esters 9 through a one-pot cycloaddition-protection-oxidation is presented as an expeditious route to enantiomerically pure 3-alkoxycarbon-yl-Delta(2)-pyrazolines in good yields and in a highly regio- and diastereoselective manner. Pyrazolidines 13 were synthesized in excellent overall yields from 9 through pyrazolines 11 and 12, the diastereoselective reduction of C=N bond being the key step. Azaprolines 16 and 17 were prepared in very good yields from epimeric trans-13 or cis-13 by oxidative deprotection of the silylated hydroxy group. In an alternative reaction, the pyrazolidine ring of 13 was reduced to obtain protected open-chain 2,4-diamino alcohols 19 with three chiral centers.
    DOI:
    10.1002/(sici)1521-3765(19990301)5:3<883::aid-chem883>3.0.co;2-0
点击查看最新优质反应信息

同类化合物

阿扎次黄嘌呤 钠2-氨基-6-甲基-[1,2,4]三唑并[1,5-a]嘧啶-5-醇 苯酚,4-[2-[[7-氨基-2-(2-呋喃基)[1,2,4]三唑并[1,5-a][1,3,5]三嗪-5-基]氨基]乙氧基]- 替格雷洛-d7 替格瑞洛羟基杂质 替格瑞洛杂质R1788033-05-5摩科品牌提供图谱 替格瑞洛杂质K 替格瑞洛杂质J 替格瑞洛杂质H 替格瑞洛杂质F 替格瑞洛杂质85 替格瑞洛杂质27 替格瑞洛杂质 替格瑞洛杂质 替格瑞洛中间体1脱保护杂质 替格瑞洛 曲匹地尔 异亚丙基替卡格雷 布美地尔 唑嘧菌胺 唑嘧磺草胺 吡唑并[1,5-a]嘧啶-7(4H)-酮,2-甲基-6-硝基-,盐钠 去羟基乙氧基替格雷洛 去羟基乙氧基-2,3-O-(二甲基亚甲基)替格雷洛 化合物 T15173 v-三唑并[4,5-d]嘧啶,(3H),3-环戊基-7-偏基硫代- [[[3-(4,7-二氢-7-氧代-1H-1,2,3-三唑并[4,5-d]嘧啶-5-基)-4-丙氧基苯基]氨基]亚甲基]丙二酸二乙酯 [1,2,4]噻唑并[1,5-c]嘧啶-5(6h)-酮 [1,2,4]三氮唑并[1,5-A]嘧啶-2-胺 [1,2,4]三唑并[3,4-f]嘧啶 [1,2,4]三唑并[1,5-a]嘧啶-7-酚,5-壬基- [1,2,4]三唑并[1,5-a]嘧啶-7(1H)-酮,2-甲基-6-硝基-,盐钠 [1,2,4]三唑并[1,5-A]嘧啶-2-羧酸甲酯 [1,2,4]三唑并[1,5-A]嘧啶-2-羧酸 [1,2,4]三唑[1,5,A]嘧啶-7-氨基 [(1R,3S)-3-(5-氨基-7-氯-3H-[1,2,3]三唑并[4,5-d]嘧啶-3-基)环戊基]甲醇 [(1R,3S)-3-(5,7-二氨基-3H-[1,2,3]三唑并[4,5-d]嘧啶-3-基)环戊基]甲醇 N-甲基-1H-1,2,3-三唑并[4,5-d]嘧啶-7-胺 N-(4'-氟丁酰苯)-4-(4-氯苯基)吡啶正离子 N-(2,6-二氯苯基)-5,7-二甲基[1,2,4]三唑并[1,5-a]嘧啶-2-磺酰胺 N-(2,6-二氯-3-甲苯基)-5,7-二甲氧基-[1,2,4]三唑[1,5-a]嘧啶-2-磺酰胺 N-(2,6-二氯-3-甲基苯基)-5,7-二氯-1,2,4-三唑并[1,5-a]吡啶-2-磺酰胺 N-(1,5,6,7-四氢-3,6-二甲基-5,7-二氧代-1,2,4-三唑并[4,3-c]嘧啶-8-基)-乙酰胺 EED抑制剂(EEDINHIBITOR-1) 9H-7,8-二氢-(1,2,3)三唑并(4',5'-4,5)嘧啶并(6,1-b)(1,3)噻嗪-5(3H)-酮 9-乙基-2,4,7,8,9-五氮杂双环[4.3.0]壬-1,3,5,7-四烯-3,5-二胺 8-甲氧基-3-甲基-[1,2,4]三唑并[4,3-C]嘧啶 8-甲基-1,3,7,9-四氮杂双环[4.3.0]壬-2,4,6,8-四烯 8-溴-[1,2,4]三唑并[4,3-c]嘧啶 8-溴-5-(甲硫基)[1,2,4]三唑并[4,3-c]嘧啶